Latest filing published 31 Jan 2025 for Black Diamond Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Mark A. Velleca: trading record in brief
Mark A. Velleca is a declared insider at 2 companies (board member); the most frequent names are G1 Therapeutics, Inc. and Black Diamond Therapeutics, Inc. The record holds 103 filings, for trades running from 18 December 2017 to 30 January 2025.
Every open-market trade on record is a sale: 48 sales worth €7.7M. Outside the open market, there are 8 share grants and 46 option exercises.
The newest entry dates from 31 January 2025: a share grant, in Black Diamond Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark A. Velleca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75,000 shares0Common StockSEC:0001415889-25-002494:0
- 5,208 shares@ US$3.6018.7% of flowCommon StockSEC:0001415889-23-013339:0
- 57,286 shares@ US$1.99861.3% of flowCommon StockSEC:0001562180-23-006271:1
- 2,714 shares@ US$0.300.0% of flowCommon StockSEC:0001562180-23-006271:2
- 2,714 shares@ US$2.020.1% of flowCommon StockSEC:0001562180-23-006271:3
- 57,286 shares@ US$0.3920.5% of flowCommon StockSEC:0001562180-23-006271:0
- 8,929 shares@ US$2.1018.2% of flowCommon StockSEC:0001415889-23-009959:0
- 11,228 shares@ US$1.6718.8% of flowCommon StockSEC:0001415889-23-005218:0
- 8,424 shares@ US$1.5012.6% of flowCommon StockSEC:0001415889-22-012797:0
- 15,000 shares@ US$11.69932.1% of flowCommon StockSEC:0001562180-22-007293:1
- 15,000 shares@ US$0.396.0% of flowCommon StockSEC:0001562180-22-007293:0
- 20,000 shares@ US$13.50223.3% of flowCommon StockSEC:0001562180-22-006791:1
- 20,000 shares@ US$0.397.9% of flowCommon StockSEC:0001562180-22-006791:0
- 4,294 shares@ US$2.6212.0% of flowCommon StockSEC:0001415889-22-009773:0
- 80,000 shares@ US$12.636312.0% of flowCommon StockSEC:0001562180-22-006214:1
- 80,000 shares@ US$0.3930.8% of flowCommon StockSEC:0001562180-22-006214:0
- 5,542 shares@ US$2.0311.3% of flowCommon StockSEC:0001415889-22-006741:0
- 2,897 shares@ US$3.028.4% of flowCommon StockSEC:0001415889-22-003185:0
- 15,000 shares@ US$0.395.1% of flowCommon StockSEC:0001562180-22-001223:0
- 40,000 shares@ US$0.3913.5% of flowCommon StockSEC:0001562180-21-006964:0
- 10,000 shares@ US$19.45362.5% of flowCommon StockSEC:0001562180-21-004949:1
- 10,000 shares@ US$0.390.0% of flowCommon StockSEC:0001562180-21-004949:2
- 10,000 shares@ US$19.08242.4% of flowCommon StockSEC:0001562180-21-004949:3
- 10,000 shares@ US$0.390.0% of flowCommon StockSEC:0001562180-21-004949:4
- 10,000 shares@ US$18.48982.3% of flowCommon StockSEC:0001562180-21-004949:5
25 of 103 declarations
